We are live on ! Find out more
ONC

BeOne Medicines Ltd

238 hedge funds and large institutions have $10.4B invested in BeOne Medicines Ltd in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 99 increasing their positions, 78 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more call options, than puts

Call options by funds: $23.6M | Put options by funds: $14M

27% more repeat investments, than reductions

Existing positions increased: 99 | Existing positions reduced: 78

0.04% less ownership

Funds ownership: 4.17%4.13% (-0.04%)

9% less funds holding

Funds holding: 262238 (-24)

17% less funds holding in top 10

Funds holding in top 10: 1210 (-2)

31% less capital invested

Capital invested by funds: $15B → $10.4B (-$4.65B)

48% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 42

Holders
238
Holders Change
-24
Holders Change %
-9.16%
% of All Funds
3.75%
Holding in Top 10
10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-16.67%
% of All Funds
0.16%
New
22
Increased
99
Reduced
78
Closed
42
Calls
$23.6M
Puts
$14M
Net Calls
+$9.69M
Net Calls Change
+$106M
Name Holding Trade Value Shares
Change
Change in
Stake
TD Asset Management
76
TD Asset Management
Ontario, Canada
$4.52M -$119K -561 -2%
KFA
77
Krane Funds Advisors
New York
$4.33M +$420K +1,974 +9%
SAM
78
Storebrand Asset Management
Norway
$4.27M +$203K +955 +4%
Aviva
79
Aviva
United Kingdom
$4.1M +$42.5K +200 +0.9%
Manulife (Manufacturers Life Insurance)
80
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4.01M +$2.61M +12,275 +155%
Zurich Cantonal Bank
81
Zurich Cantonal Bank
Switzerland
$3.95M +$839K +3,948 +23%
BCIM
82
British Columbia Investment Management
British Columbia, Canada
$3.86M +$250K +1,175 +6%
Citigroup
83
Citigroup
New York
$3.4M -$2.04M -9,619 -35%
Handelsbanken Fonder
84
Handelsbanken Fonder
Sweden
$3.3M +$213K +1,000 +6%
Public Sector Pension Investment Board (PSP Investments)
85
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$3.19M +$42.5K +200 +1%
State of New Jersey Common Pension Fund D
86
State of New Jersey Common Pension Fund D
New Jersey
$3.18M
Swedbank
87
Swedbank
Sweden
$3.1M
Mitsubishi UFJ Asset Management
88
Mitsubishi UFJ Asset Management
Japan
$3.03M +$357K +1,681 +12%
Bank of Montreal
89
Bank of Montreal
Ontario, Canada
$3M +$509K +2,396 +20%
AllianceBernstein
90
AllianceBernstein
Tennessee
$2.94M +$2.23M +10,477 +205%
Dimensional Fund Advisors
91
Dimensional Fund Advisors
Texas
$2.94M +$435K +2,047 +15%
Stifel Financial
92
Stifel Financial
Missouri
$2.88M +$258K +1,213 +9%
RJA
93
Raymond James & Associates
Florida
$2.88M +$648K +3,047 +25%
PFM
94
Privium Fund Management
Netherlands
$2.83M +$3.19M +15,000 New
KBC Group
95
KBC Group
Belgium
$2.68M +$26.6K +125 +0.9%
LCAM
96
Long Corridor Asset Management
Hong Kong
$2.56M +$765K +3,600 +36%
NFGH
97
Nan Fung Group Holdings
Hong Kong
$2.27M +$174K +817 +7%
EAM
98
Erste Asset Management
Austria
$2.27M -$319K -1,500 -12%
OAM
99
Oppenheimer Asset Management
New York
$2.25M -$274K -1,291 -10%
HT
100
HAP Trading
New York
$2.1M +$2.37M +11,152 New

ONC Hedge Fund Activity: Q1 2022 in Review

238 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q1 2022, worth a combined $10.4B — down 31% from $15B a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of ONC and 22 opened new positions — a net loss of 20 holders — while 78 trimmed existing stakes and 99 added.

The largest buyer was Capital International Investors, adding an estimated $151M. The largest seller was Wellington Management Group, cutting an estimated $144M.

  • 238 institutional investors held BeOne Medicines Ltd (ONC) as of Q1 2022, down from 262 in Q4 2021.
  • Funds reported $10.4B of BeOne Medicines Ltd stock for Q1 2022, down 31% quarter-over-quarter.
  • 22 funds opened new BeOne Medicines Ltd positions in Q1 2022 and 42 closed out, a net change of -20 holders.
  • The largest BeOne Medicines Ltd buyer in Q1 2022 was Capital International Investors, an estimated $151M added.
  • The largest BeOne Medicines Ltd seller in Q1 2022 was Wellington Management Group, an estimated $144M sold.

Based on aggregated 13F filings for Q1 2022.